ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
51 announcements
Q2 revenue ₹271 Cr (+51% YoY, +43% constant currency), adjusted EBITDA ₹44.8 Cr at 17% margin. Organic H1 growth is 23%; inorganic (Session M) doubled and drove the headline.
Capillary Technologies allotted 94,553 equity shares of ₹2 each upon exercise of vested ESOP 2021 options. The allotment was approved by circular resolution on November 04, 2026.
Capillary Technologies announced the strategic shutdown of its China operations due to low growth. Both quantitative and qualitative effects of the restructuring are stated as nil.
Capillary Technologies replaced internal auditor Protiviti with Deloitte Touche Tohmatsu India LLP on a 15-month term. The board cited expanding international operations as the reason.
Capillary Technologies appointed Deloitte Touche Tohmatsu India LLP as Internal Auditor, replacing Protiviti India. The change takes effect November 02, 2026.
Capillary announced Q2 FY27 revenue of ₹2,713.5 Mn (+51% YoY) and Adjusted EBITDA of ₹448.6 Mn (+103%). H1 FY27 revenue grew 47% with EBITDA up 116%.
Q2 FY27 revenue ₹2,713.5 Mn (+51% YoY), Adj. EBITDA ₹448.6 Mn (17% margin), PAT ₹219.2 Mn. H1 PAT ₹123.7 Mn after ₹333.9 Mn cyber-fraud exceptional loss. Organic NRR 116%.
Capillary Technologies completed the deregistration of its dormant China subsidiary, Capillary Shanghai. The closure has no impact on the company's operations or financials.
Capillary Technologies India Ltd reported revenue from operations of ₹271.4 Cr (+51.4% YoY) and net profit of ₹21.9 Cr (+7200.0% YoY) for Q2 FY27.
Capillary Technologies received KPMG's final forensic report on a cyber-enabled payment fraud at a step-down subsidiary. Four disputed payments totalled EUR 3.04 million, about Rs.32.24 Crore.
Capillary Technologies schedules a board meeting on 02 November 2026 to approve unaudited quarterly standalone and consolidated results. Trading window stays closed from 01 October to 04 November 2026.
Capillary Technologies India Limited appointed Mr. William Earl Swift as Senior Management Personnel overseeing operations across the Americas. Mr. Swift previously served as Brierley's CEO.
Capillary Technologies India Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026. This is a routine regulatory compliance disclosure.
Capillary Technologies clarified that recent stock price movement is market-driven and that the company has disclosed all material information as required by SEBI regulations.
Kotak Mahindra Mutual Fund acquired 93,281 shares of Capillary Technologies, crossing the 5% ownership threshold. No transaction value was disclosed in the Reg 29(1) filing.
Mirae Asset Mutual Fund decreased its shareholding in Capillary Technologies India Ltd by selling 1,75,842 shares. This disclosure was filed under SEBI SAST regulations.
Capillary Technologies India Limited appointed seven senior management personnel including Mr. Rishi Pratim Ray as Director - Finance. The appointments across finance, legal, and regional leadership take effect from September 1, 2026.
Capillary Technologies India Limited held its 14th Annual General Meeting on August 28, 2026. The meeting covered the adoption of financial statements and the re-appointment of a director.
Capillary Technologies clarified that the promoter's recent 4% equity sale was a liquidity event for an investor, not a change in founder commitment or strategy.
Kotak Mahindra Mutual Fund acquired additional shares in Capillary Technologies India Ltd, increasing its stake to over 5.00%. The fund acquired 93,281 shares, representing a 0.1174% stake.
Promoter Capillary Technologies International Pte. Ltd. sold 3,292,428 shares (4.14% stake) in Capillary Technologies India Ltd via a block deal. The promoter's holding decreased to 44.78%.
Q1 FY27 revenue grew 43% YoY to INR 256 Cr. Management is leveraging AI-led migrations and SessionM acquisition to drive EBITDA margin expansion (17% overall, 20% organic).
Capillary Technologies acquired the CustomerGlu software platform and intellectual property from Marax AI, Inc. The acquisition integrates GenAI-powered gamification tools into Capillary's loyalty platform.
Capillary Technologies reported Q1 FY2027 revenue of ₹256.64 Crore, a 43% year-on-year increase. Profitability improved with Adjusted EBITDA rising 132% to ₹44.02 Crore.
Capillary Technologies reported Q1 FY27 revenue of ₹2,566.4 Mn (up 43% YoY) and Adjusted EBITDA of ₹440.2 Mn (up 132% YoY), despite an exceptional loss from a cyber fraud incident.
Capillary Technologies India Ltd reported revenue from operations of ₹256.6 Cr (+42.6% YoY) and a net loss of ₹9.6 Cr for Q1 FY27.
Capillary Technologies informs shareholders about the availability of the 14th AGM notice and Annual Report 2025-26 via electronic links, per SEBI regulations.
Capillary Technologies India Limited has submitted its Business Responsibility and Sustainability Report for the financial year ended March 31, 2026, as per SEBI regulations.
Capillary Technologies India Limited filed its Integrated Annual Report for FY 2025-26, including the notice for the 14th Annual General Meeting.
Capillary Technologies India Limited has issued the notice for its 14th Annual General Meeting scheduled for August 28, 2026. The meeting will be conducted via video conferencing.